Vivos Therapeutics Inc. (VVOS) Price to Earnings Ratio

Corporate emblem and logo of Vivos Therapeutics Inc. (VVOS)

Vivos Therapeutics (VVOS) is actively expanding its presence in the dental apnea systems segment, having secured critical FDA clearances for its next growth phase. The business leverages an extensive global network of clinics and physicians, which minimizes the impact of local insurance payouts. The stock price history demonstrates a current metric of -0.10. The company's revenue stability is being bolstered by an influx of new partners, ensuring moderate revenue predictability.

Vivos Therapeutics Inc (VVOS) Price to Earnings Ratio: for the period 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for Vivos Therapeutics, Inc. (VVOS)

- price and consensus price forecast:
Stock Price Vivos Therapeutics Inc.|VVOS - Price Target Chart
- market capitalization details:
Market Value Vivos Therapeutics Inc.|VVOS - Enterprise Value
- book capitalization information:
Net Assets per Share Vivos Therapeutics|VVOS - Company Net Assets|Market Capitalization to Net Assets vivoslife.com|VVOS - Company Total Assets
- debt and solvency information:
Debt to Capital Vivos Therapeutics|VVOS - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Vivos Therapeutics, Inc.|VVOS - Company Total Debt|Debt to Net Assets Ratio Vivos Therapeutics, Inc|VVOS - Company Long-Term Debt|Company Current Liabilities Vivos Therapeutics|Immediate Liquidity vivoslife.com
- earnings and market multiples details:
VVOS - Net Profit|Net Profit Forecast Vivos Therapeutics|VVOS - P/E Multiple|Market Cap to Projected Earnings Vivos Therapeutics, Inc|VVOS - PEG Multiple|Enterprise Value to EBITDA Ratio Vivos Therapeutics Inc.|VVOS - Operating profit EBITDA|Net earnings per share (EPS TTM) Vivos Therapeutics|VVOS - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months vivoslife.com|VVOS - Net earnings per share growth this year|Expected earnings per share trend next year Vivos Therapeutics
- issuer revenue and sales details:
VVOS - Revenue and Sales Volume|Company Expected Sales Volume Vivos Therapeutics Inc.|VVOS - Price-to-Revenue Ratio|Projected Price to Revenue Vivos Therapeutics Inc
General company analysis:Vivos Therapeutics Inc. - VVOS
Original product of vivoslife.com

Diversifying distribution channels for apnea treatment systems through dental and medical centers reduces Vivos Therapeutics (VVOS) dependence on local insurance tariffs. A P/E valuation analysis demonstrates the ratio of market capitalization to net income, reflecting the market value of management's efforts; meanwhile, a prolonged decline in this metric signals systemic capital depreciation rather than an undervalued asset.

Analysis of competing companies

Price to Earnings Ratio BSX|Price to Earnings Ratio EW (Edwards Lifesciences Corporation)|Business Payback Period ResMed Inc.|P/E Multiple PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Market Cap to Net Income|CooperSurgical - P/E Multiple|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Group (TMDX)|ATEC (Alphatec) - P/E Multiple|Price to Earnings Multiple AORT (Artivion)|Price to Earnings Ratio ENOV (Enovis)|IART (Integra LifeSciences Corp) - Company Value to Net Income|Price to Earnings Ratio Establishment Labs Inc ESTA|BBNX - Price to Earnings Ratio|IRADIMED Corp - P/E Multiple|Market Cap to Earnings Embecta Corp.|TNDM: P/E Multiple|Price to Earnings Multiple AXGN|SIBN (SI-BONE Medical) - P/E Multiple|Orthofix International (OFIX) - Business Payback Period|P/E Multiple BVS|Price to Earnings Ratio OrthoPediatrics KIDS|P/E Multiple TMCI (treace.com)|P/E Multiple Blade Air Mobility SRTA|CARL - Price to Earnings Ratio|RXST: Price to Earnings Ratio|CLPT (ClearPoint) - Price to Earnings Ratio|Stereotaxis, Inc. - Company Value to Net Income|STIM (Neuronetics, Inc) - P/E Multiple|Market Cap to Earnings Sight Sciences Inc. SGHT|Price to Earnings Ratio orchestrabiomed.com (OBIO)|Anika (ANIK) - Market Cap to Net Income Ratio|InspireMD Inc. - Price to Earnings Ratio|P/E Multiple Jin Medical International Ltd ZJYL|Vivani Medical Inc - P/E Multiple|Business Payback Period Xtant Medical XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Price to Earnings Ratio|Market Cap to Net Income MODD (Modular Med)|MYO (Myomo Inc.) - P/E Multiple|Price to Earnings Ratio Envoy Medical, Inc. (COCH)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical, Inc. TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|Business Payback Period invobioscience.com IVF|BBLG: P/E Multiple|Axonics Modulation Technologies (AXNX) - P/E Multiple|BIOL (Biolase Inc.) - P/E Multiple|Market Cap to Earnings dynatronics.com DYNT|P/E Multiple FNA|Price to Earnings Ratio INVO (INVO Bioscience Inc.)